A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia

Nephrology Dialysis Transplantation

Volumn 21, Issue 4, 2006, Pages 968-974

  Basile, Carlo ^a,c   Lomonte, Carlo ^a   Vernaglione, Luigi ^b   Casucci, Francesco ^a   Chimienti, Domenico ^a   Bruno, Andrea ^a   Cocola, Savino ^a   Verrelli, Erminia Antonicelli ^a   Cazzato, Francesco ^a  

^a MIULLI GENERAL HOSPITAL   (Italy)

^b Hospital of Manduria   (Italy)

^c NONE   (Italy)

Author keywords

Body mass index; Female gender; Haemodialysis; Hyperparathyroidism; Parathyroidectomy; Phosphataemia

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; PHOSPHATE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CAUCASIAN; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HEMODIALYSIS PATIENT; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NODULAR HYPERPLASIA; PARATHYROID HYPERPLASIA; PARATHYROIDECTOMY; PATIENT REFERRAL; PHOSPHATE BLOOD LEVEL; PREDICTION; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SCORING SYSTEM; SECONDARY HYPERPARATHYROIDISM; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; UREMIA;

BODY MASS INDEX; CHRONIC DISEASE; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPERPLASIA; MALE; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROIDECTOMY; RENAL DIALYSIS; RISK FACTORS; SEX FACTORS; UREMIA;

EID: 33645286481     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi311     Document Type: Article

References (20)

1. Malberti F, Marcelli D, Conte F, Limido A, Spotti D, Locatelli F. Parathyroidectomy in patients on renal replacement therapy: An epidemiologic study. J Am Soc Nephrol 2001; 12:1242-1248
2. Foley RN, Li S, Liu J, Gilbertson DT, Chen S-C, Collins AJ. The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. J Am Soc Nephrol 2005; 16: 210-218
3. Rodriguez M, Canalejo A, Garfia B, Aguilera E, Almaden Y. Pathogenesis of refractory secondary hyperparathyroidism. Kidney Int 2002; 61: S155-S160
4. Casino FG, Basile C, Gaudiano V, Lopez T. A modified algorithm of the single pool urea kinetic model. Nephrol Dial Transplant 1990; 5: 214-219
5. Kazama JJ, Sato F, Omori K et al. Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients. Kidney Int 2005; 67: 1120-1125
6. Lomonte C, Martino R, Selvaggiolo M et al. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients. J Nephrol 2003; 16: 716-720
7. Custodio MR, Montenegro F, Costa AFP et al. MIBI scintigraphy, indicators of cell proliferation and histology of parathyroid glands in uraemic patients. Nephrol Dial Transplant 2005; 20: 1898-1903
8. NKF/K-DOQI Bone metabolism and disease in chronic kidney disease. Guideline 14: PTx in patients with CKD. Am J Kidney Dis 2003; 42: S127-S129
9. Naveh-Many T, Almogi G, Livni N, Silver J. Estrogen receptors and biologic response in rat parathyroid tissue and C cells. J Clin Invest 1992; 90: 2434-2438
10. Prince RL. Estrogen effects on calciotrophic hormones and calcium homeostasis. Endocr Rev 1994; 15: 301-309
11. Lomonte C, Cazzato F, Casucci F et al. Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands. J Nephrol 2005; 18: 92-95
12. Drüeke TB. Parathyroid gland hyperplasia in uremia. Kidney Int 2001; 58: 1182-1183
13. Arnold A, Brown MF, Ureña P, Gaz RD, Sarfati E, Drüeke TB. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995; 95: 2042-2054
14. Spalding EM, Chamney PW, Farrington K. Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int 2002; 61: 655-667
15. Kalaitzidis R, Tsimihodimos V, Bairaktari E, Siamopoulos KC, Elisaf M. Disturbances of phosphate metabolism: Another feature of metabolic syndrome. Am J Kidney Dis 2005; 45: 851-858
16. Indridason OS, Pieper CF, Quarles LD. Predictors of short-term changes in serum parathyroid hormone levels in hemodialysis patients: Role of phosphorus, calcium and gender. J Clin Endocrinol Metab 1998; 83: 3860-3866
17. Gupta A, Kallenbach LR, Zasuwa G, Divine GW. Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol 2000; 11: 330-334
18. Almaden Y, Felsenfeld AJ, Rodriguez M et al. Proliferation in hyperplastic human and normal rat parathyroid glands: Role of phosphate, calcitriol, and gender. Kidney Int 2003; 64: 2311-2317
19. Pazianas M, Phillips ME, MacRae KD, Eastwood JB. Identification of risk factors for radiographic hyperparathyroidism in 422 patients with end-stage renal disease: Development of a clinical predictive index. Nephrol Dial Transplant 1992; 7: 1098-1105
20. Taal MW, Masud T, Green D, Cassidy MJ. Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant 1999; 14: 1922-1928